2020
DOI: 10.1111/bcpt.13420
|View full text |Cite
|
Sign up to set email alerts
|

Response to the Letter to the Editor entitled “Correlation of registered drug packs in Greece with Maastricht V/Florence and Hellenic Helicobacter pylori infection treatment Consensuses: A poor or a proper match?”

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
3

Relationship

3
0

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…Our previous research showed poor adherence of drug packaging with European and national guidelines for management of H pylori infection for a portion of EU countries. Unavailability of drugs that are an integral part of the first treatment line is also important problem for implementation of Maastricht V/Florence consensus report in clinical practice 30,31 . Furthermore, most recent data on H. pylori resistance rate in Croatia were published in 2012 13 …”
Section: Discussionmentioning
confidence: 99%
“…Our previous research showed poor adherence of drug packaging with European and national guidelines for management of H pylori infection for a portion of EU countries. Unavailability of drugs that are an integral part of the first treatment line is also important problem for implementation of Maastricht V/Florence consensus report in clinical practice 30,31 . Furthermore, most recent data on H. pylori resistance rate in Croatia were published in 2012 13 …”
Section: Discussionmentioning
confidence: 99%